Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades

Endocrinology

Volumn 151, Issue 11, 2010, Pages 5537-5549

  Morshed, Syed A ^a   Ando, Takao ^a   Latif, Rauf ^a   Davies, Terry F ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 7; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INTERACTING KINASE 1; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; PROTEIN KINASE C; RIBOSOMAL KINASE P90; RIBOSOME PROTEIN; S6 KINASE; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; CYTOKINE; PROTEIN KINASE B; THYROTROPIN RECEPTOR;

ANIMAL CELL; ANTIBODY DETECTION; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAVES DISEASE; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEOMICS; RAT; SIGNAL TRANSDUCTION; THYMOCYTE; THYROID CELL; ANIMAL; CELL CULTURE; CYTOLOGY; FLOW CYTOMETRY; HAMSTER; IMMUNOLOGY; METABOLISM; MOUSE; THYROID GLAND; TISSUE MICROARRAY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; AUTOANTIBODIES; BLOTTING, WESTERN; CELLS, CULTURED; CRICETINAE; CYTOKINES; FLOW CYTOMETRY; GRAVES DISEASE; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTORS, THYROTROPIN; SIGNAL TRANSDUCTION; THYROID GLAND; TISSUE ARRAY ANALYSIS;

EID: 78049504505     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0424     Document Type: Article

References (59)

1. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, Roger PP 2001 Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev 22:631-656
2. Medina DL, Santisteban P 2000 Thyrotropin-dependent proliferation of in vitro rat thyroid cell systems. Eur J Endocrinol 143:161-178
3. Ando T, Latif R, Pritsker A, Moran T, Nagayama Y, Davies TF 2002 A monoclonal thyroid-stimulating antibody. J Clin Invest 110: 1667-1674
4. Ando T, Latif R, Daniel S, Eguchi K, Davies TF 2004 Dissecting linear and conformational epitopes on the native thyrotropin receptor. Endocrinology 145:5185-5193
5. Ando T, Latif R, Davies TF 2004 Concentration-dependent regulation of thyrotropin receptor function by thyroid-stimulating antibody. J Clin Invest 113:1589-1595
6. Sanders J, Jeffreys J, Depraetere H, Richards T, Evans M, Kiddie A, Brereton K, Groenen M, Oda Y, Furmaniak J, Rees Smith B 2002 Thyroid-stimulating monoclonal antibodies. Thyroid 12:1043-1050
7. Sanders J, Jeffreys J, Depraetere H, Evans M, Richards T, Kiddie A, Brereton K, Premawardhana LD, Chirgadze DY, Núñez Miguel R, Blundell TL, Furmaniak J, Rees Smith B 2004 Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. Thyroid 14:560-570
8. Sanders J, Allen F, Jeffreys J, Bolton J, Richards T, Depraetere H, Nakatake N, Evans M, Kiddie A, Premawardhana LD, Chirgadze DY, Miguel RN, Blundell TL, Furmaniak J, Smith BR 2005 Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist. Thyroid 15:672-682
9. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM 1998 The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 19:673-716
10. Tonacchera M, Costagliola S, Cetani F, Ducobu J, Stordeur P, Vassart G, Ludgate M 1996 Patient with monoclonal gammopathy, thyrotoxicosis, pretibial myxedema and thyroid-associated ophthalmopathy; demonstration of direct binding of autoantibodies to the thyrotropin receptor. Eur J Endocrinol 134:97-103
11. Minich WB, Loos U 2000 Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis. Exp Clin Endocrinol Diabetes 108:110-119
12. Nagy EV, Burch HB, Mahoney K, Lukes YG, Morris 3rd JC, Burman KD 1992 Graves' IgG recognizes linear epitopes in the human thyrotropin receptor. Biochem Biophys Res Commun 188:28-33
13. Vlase H, Graves PN, Magnusson RP, Davies TF 1995 Human autoantibodies to the thyrotropin receptor: recognition of linear, folded, and glycosylated recombinant extracellular domain. J Clin Endocrinol Metab 80:46-53
14. Latif R, Morshed SA, Zaidi M, Davies TF 2009 The thyroid-stimulating hormone receptor: impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on multimerization, cleavage, and signaling. Endocrinol Metab Clin North Am 38:319-341, viii
15. Michalek K, Morshed SA, Latif R, Davies TF 2009 TSH receptor autoantibodies. Autoimmun Rev 9:113-116
16. Morshed SA, Latif R, Davies TF 2009 Characterization of thyrotropin receptor antibody-induced signaling cascades. Endocrinology 150:519-529
17. Büch TR, Biebermann H, Kalwa H, Pinkenburg O, Hager D, Barth H, Aktories K, Breit A, Gudermann T 2008 G13-dependent activation of MAPK by thyrotropin. J Biol Chem 283:20330-20341
18. Ciullo I, Diez-Roux G, Di Domenico M, Migliaccio A, Avvedimento EV 2001 cAMP signaling selectively influences Ras effectors pathways. Oncogene 20:1186-1192
19. Corrèze C, Blondeau JP, Pomérance M 2005 p38 mitogen-activated protein kinase contributes to cell cycle regulation by cAMP in FRTL-5 thyroid cells. Eur J Endocrinol 153:123-133
20. Devlin MA, Das S, Singh I, Bourgoin S, Brindley DN, Ginsberg J 2000 The characterization of phospholipase D in FRTL-5 thyroid cells. Mol Cell Endocrinol 167:107-115
21. Iacovelli L, Capobianco L, Salvatore L, Sallese M, D'Ancona GM, De Blasi A 2001 Thyrotropin activates mitogen-activated protein kinase pathway in FRTL-5 by a cAMP-dependent protein kinase A-independent mechanism. Mol Pharmacol 60:924-933
22. McKay MM, Morrison DK 2007 Integrating signals from RTKs to ERK/MAPK. Oncogene 26:3113-3121
23. Saavedra AP, Tsygankova OM, Prendergast GV, Dworet JH, Cheng G, Meinkoth JL 2002 Role of cAMP, PKA and Rap1A in thyroid follicular cell survival. Oncogene 21:778-788
24. Suh JM, Song JH, Kim DW, Kim H, Chung HK, Hwang JH, Kim JM, Hwang ES, Chung J, Han JH, Cho BY, Ro HK, Shong M 2003 Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland. J Biol Chem 278:21960-21971
25. Urso L, Muscella A, Calabriso N, Ciccarese A, Fanizzi FP, Migoni D, Di Jeso B, Storelli C, Marsigliante S 2005 Differential functions of PKC-Δ and PKC-ζ in cisplatin response of normal and transformed thyroid cells. Biochem Biophys Res Commun 337:297-305 (Pubitemid 41393793)
26. Woloshin PI, Walton KM, Rehfuss RP, Goodman RH, Cone RD 1992 3′,5′-cyclic adenosine monophosphate-regulated enhancer binding (CREB) activity is required for normal growth and differentiated phenotype in the FRTL5 thyroid follicular cell line. Mol Endocrinol 6:1725-1733
27. Sanders J, Chirgadze DY, Sanders P, Baker S, Sullivan A, Bhardwaja A, Bolton J, Reeve M, Nakatake N, Evans M, Richards T, Powell M, Miguel RN, Blundell TL, Furmaniak J, Smith BR 2007 Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid 17:395-410 (Pubitemid 46878842)
28. Ando T, Latif R, Davies TF 2007 Antibody-induced modulation of TSH receptor post-translational processing. J Endocrinol 195:179-186 (Pubitemid 350056011)
29. Laugwitz KL, Allgeier A, Offermanns S, Spicher K, Van Sande J, Dumont JE, Schultz G 1996 The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families. Proc Natl Acad Sci USA 93:116-120 (Pubitemid 26038113)
30. Ambesi-Impiombato FS, Parks LA, Coon HG 1980 Culture of hormone-dependent functional epithelial cells from rat thyroids. Proc Natl Acad Sci USA 77:3455-3459 (Pubitemid 10012253)
31. Narayanan PK, Ragheb K, Lawler G, Robinson JP 1997 Defects in intracellular oxidative metabolism of neutrophils undergoing apoptosis. J Leukoc Biol 61:481-488 (Pubitemid 27219842)
32. Rozengurt E 2007 Mitogenic signaling pathways induced by G protein-coupled receptors. J Cell Physiol 213:589-602 (Pubitemid 350058250)
33. Salminen A, Suuronen T, Huuskonen J, Kaarniranta K 2008 NEMO shuttle: a link between DNA damage and NF-κB activation in progeroid syndromes? Biochem Biophys Res Commun 367:715-718
34. Takai O, Desai RK, Seetharamaiah GS, Jones CA, Allaway GP, Akamizu T, Kohn LD, Prabhakar BS 1991 Prokaryotic expression of the thyrotropin receptor and identification of an immunogenic region of the protein using synthetic peptides. Biochem Biophys Res Commun 179:319-326
35. Dremier S, Vandeput F, Zwartkruis FJ, Bos JL, Dumont JE, Maenhaut C 2000 Activation of the small G protein Rap1 in dog thyroid cells by both cAMP-dependent and -independent pathways. Biochem Biophys Res Commun 267:7-11 (Pubitemid 30072498)
36. Di Benedetto G, Zoccarato A, Lissandron V, Terrin A, Li X, Houslay MD, Baillie GS, Zaccolo M 2008 Protein kinase A type I and type II define distinct intracellular signaling compartments. Circ Res 103:836-844
37. Kikumori T, Kambe F, Nagaya T, Funahashi H, Seo H 2001 Thyrotropin modifies activation of nuclear factor κB by tumour necrosis factor α in rat thyroid cell line. Biochem J 354:573-579 (Pubitemid 32269720)
38. Kim H, Suh JM, Hwang ES, Kim DW, Chung HK, Song JH, Hwang JH, Park KC, Ro HK, Jo EK, Chang JS, Lee TH, Lee MS, Kohn LD, Shong M 2003 Thyrotropin-mediated repression of class II transactivator expression in thyroid cells: involvement of STAT3 and suppressor of cytokine signaling. J Immunol 171:616-627 (Pubitemid 36871369)
39. Li Q, Verma IM 2002 NF-κB regulation in the immune system. Nat Rev Immunol 2:725-734
40. Perkins ND 2007 Integrating cell-signalling pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol 8:49-62
41. Campisi J, d'Adda di Fagagna F 2007 Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8:729-740
42. Lane DP 1992 Cancer. p53, guardian of the genome. Nature 358: 15-16
43. Valdivia A, Pérez-Alvarez S, Aroca-Aguilar JD, Ikuta I, Jordán J 2009 Superoxide dismutases: a physiopharmacological update. J Physiol Biochem 65:195-208
44. Barreto G, Madureira D, Capani F, Aon-Bertolino L, Saraceno E, Alvarez-Giraldez LD 2009 The role of catechols and free radicals in benzene toxicity: an oxidative DNA damage pathway. Environ Mol Mutagen 50:771-780
45. He J, Takano T, Ding J, Gao S, Noda C, Sada K, Yanagi S, Yamamura H 2002 Syk is required for p38 activation and G2/M arrest in B cells exposed to oxidative stress. Antioxid Redox Signal 4:509-515
46. Li PF, Dietz R, von Harsdorf R 1999 p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J 18:6027-6036
47. Li PF, Maasch C, Haller H, Dietz R, von Harsdorf R 1999 Requirement for protein kinase C in reactive oxygen species-induced apoptosis of vascular smooth muscle cells. Circulation 100:967-973 (Pubitemid 29407178)
48. Mattson MP, Chan SL 2003 Calcium orchestrates apoptosis. Nat Cell Biol 5:1041-1043
49. Nguyen TH, Mustafa FB, Pervaiz S, Ng FS, Lim LH 2008 ERK1/2 activation is required for resveratrol-induced apoptosis in MDA-MB-231 cells. Int J Oncol 33:81-92
50. Wang T, Lao U, Edgar BA 2009 TOR-mediated autophagy regulates cell death in Drosophila neurodegenerative disease. J Cell Biol 186:703-711
51. Wen L, Zhuang L, Luo X, Wei P 2003 TL1A-induced NF-κB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells. J Biol Chem 278:39251-39258
52. Ryan KM, Ernst MK, Rice NR, Vousden KH 2000 Role of NF-κB in p53-mediated programmed cell death. Nature 404:892-897
53. Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K, Linn S 2004 Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73:39-85
54. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B 2001 A subset of lupus anti-DNA antibodies crossreacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 7:1189-1193
55. He XP, Patel M, Whitney KD, Janumpalli S, Tenner A, McNamara JO 1998 Glutamate receptor GluR3 antibodies and death of cortical cells. Neuron 20:153-163
56. Kowal C, DeGiorgio LA, Nakaoka T, Hetherington H, Huerta PT, Diamond B, Volpe BT 2004 Cognition and immunity; antibody impairs memory. Immunity 21:179-188
57. Liang CS, Mao W, Liu J 2008 Pro-apoptotic effects of anti-β1- adrenergic receptor antibodies in cultured rat cardiomyocytes: actions on endoplasmic reticulum and the prosurvival PI3K-Akt pathway. Autoimmunity 41:434-441
58. Gilbert JA, Gianoukakis AG, Salehi S, Moorhead J, Rao PV, Khan MZ, McGregor AM, Smith TJ, Banga JP 2006 Monoclonal pathogenic antibodies to the thyroid-stimulating hormone receptor in Graves' disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signaling pathways. J Immunol 176:5084-5092
59. Bossowski A, Czarnocka B, Bardadin K, Stasiak-Barmuta A, Urban M, Dadan J, Ratomski K, Bossowska A 2008 Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis. Autoimmunity 41:163-173